In addition, adiponectin is negatively associated with a variety of benign and malignant tumors, especially those associated with obesity and insulin resistance, such as leukemia [76], renal carcinoma [77], gastric carcinoma [78] and colon cancer [79]. Here, ADIPOQ is linked to colonic neoplasm.